Invivyd (IVVD) Property, Plant & Equipment (Net) Growth (1y) (2022 - 2026)
Powered by 
Analysis
Invivyd (IVVD) Property, Plant & Equipment (Net) Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 24.68% |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 6.85% |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 24.71% |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 12.77% |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | -99.85% |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -5.07% |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 10.87% |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -3.38% |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 19.14% |
| 10 | Invivyd | 244.65 Mn | 84.57 Mn | 13.01 Mn | 56.82% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56.82% |
| Dec 31, 2025 | -9.48% |
| Sep 30, 2025 | -23.17% |
| Jun 30, 2025 | -21.44% |
| Mar 31, 2025 | -19.88% |
| Dec 31, 2024 | -20.46% |
| Sep 30, 2024 | -18.08% |
| Jun 30, 2024 | -16.53% |
| Mar 31, 2024 | -15.59% |
| Dec 31, 2023 | -16.91% |
| Sep 30, 2023 | 40.10% |
| Jun 30, 2023 | 2,232.97% |
| Mar 31, 2023 | 2,488.51% |
| Dec 31, 2022 | 2,649.40% |